Zobrazeno 1 - 9
of 9
pro vyhledávání: '"for the Italian Liver Cancer (ITA. LI. CA) Group"'
Autor:
Giannini E. G., Bucci L., Garuti F., Brunacci M., Lenzi B., Valente M., Caturelli E., Cabibbo G., Piscaglia F., Virdone R., Felder M., Ciccarese F., Foschi F. G., Sacco R., Svegliati Baroni G., Farinati F., Rapaccini G. L., Olivani A., Gasbarrini A., Di Marco M., Morisco F., Zoli M., Masotto A., Borzio F., Benvegnu L., Marra F., Colecchia A., Nardone G., Bernardi M., Trevisani F, Olmi S, on behalf of Italian Liver Cancer (ITA. LI. CA) group
The Barcelona Clinic Liver Cancer advanced stage (BCLC C) of hepatocellular carcinoma (HCC) includes a heterogeneous population, where sorafenib alone is the recommended treatment. In this study our aim was to assess treatment and overall survival (O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9229a7b49ea14b6ed47a849a9adbac
http://hdl.handle.net/11577/3252803
http://hdl.handle.net/11577/3252803
Autor:
Vitale, A, Lai, Q, Farinati, F, Bucci, L, Giannini, Eg, Napoli, L, Ciccarese, F, Rapaccini, Gl, Di Marco, M, Caturelli, E, Zoli, M, Borzio, F, Sacco, R, Cabibbo, G, Virdone, R, Marra, F, Felder, M, Morisco, F, Benvegnù, L, Gasbarrini, A, Svegliati-Baroni, G, Foschi, Fg, Missale, G, Masotto, A, Nardone, G, Colecchia, A, Bernardi, M, Trevisani, F, Pawlik, Tm, Italian Liver Cancer, (ITA. LI. CA) group.
Background: Dichotomous models like Milan Criteria represent the routinely used tools for predicting the outcome of patients with hepatocellular carcinoma (HCC). However, a paradigm shift from a dichotomous to continuous prognostic stratification sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d29d16b387ae48db8e8382e6f18c801
http://hdl.handle.net/11585/675216
http://hdl.handle.net/11585/675216
Autor:
F. Farinati, D. Marino, M. De Giorgio, A. Baldan, M. C. Cantarini, C. Cursaro, G. L. Rapaccini, P. Del Poggio, M. A. Di Nolfo, L. Benvegnù, M. Zoli, F. Borzio, M. Bernardi, F. Trevisani, for the Italian Liver Cancer (ITA. LI. CA) group
Publikováno v:
The American Journal of Gastroenterology. 101:524-532
The clinical usefulness of alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC) management is debatable.To assess, in a large multi-centric survey, diagnostic and prognostic reliability of AFP, predictive factors, and any correlation with the tu
Autor:
Farinati Fabio, Giacomin Anna, Vanin Veronica, Sergio Adriana, Burra Patrizia, Cillo Umberto, Di Nolfo Annamaria, Del Poggio Paolo, Benvegnu Luisa, Zoli Marco, Borzio Franco, Giannini Edoardo, Caturelli Eugenio, Cazzagon Nora, Rapaccini Gian Ludovico, Trevisani Franco, for the Italian Liver Cancer (ITA. LI. CA) group, Andreone P, Bernardi M, Biselli M, Caraceni P, di Micoli A, Domenicali M, Magalotti D, Cappa FM, Santi V, Zambruni A, Balsamo C, Di Marco M, Vavassori E, Gilardoni L, Mattiello M, Alberti A, Gatta A, Gios M, Molaro M, Sala M, Savarino V, Risso D, Ghittoni G, Roselli P, Grazi GL, Nardo B, Ravaioli M, Pinna AD, Giampalma E, Golfieri R
Publikováno v:
European journal of gastroenterologyhepatology. 24(2)
INTRODUCTION: Hepatocellular carcinoma (HCC) is an established indication for liver transplantation (LT), but the selection criteria and priority are still debated. AIMS: To ascertain the number and features of patients with HCC who undergo transplan
Autor:
F. Mirici Cappa, G. Magini, V. Santi, R. Casadio, M. A. Di Nolfo, P. Del Poggio, L. Benvegnù, G. Rapaccini, G. Farinati, M. Zoli, F. Borzio, E. G. Giannini, E. Caturelli, M. Bernardi, F. Trevisani, for the Italian Liver Cancer (ITA. LI. CA) group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::d70d5d5143f1487535bbcc6cc34a556e
http://hdl.handle.net/11585/57262
http://hdl.handle.net/11585/57262
Autor:
Franco Trevisani, Giulia Magini, Valentina Santi, Antonio Maria Morselli-Labate, Maria Chiara Cantarini, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gianludovico Rapaccini, Fabio Farinati, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Mauro Bernardi, for the Italian Liver Cancer (ITA. LI. CA) Group, Pietro Andreone, Maurizio Biselli, Paolo Caraceni, Carmela Cursaro, Marco Domenicali, Annagiulia Gramenzi, LI BASSI, SILVIA, Donatella Magalotti, Federica Mirici Cappa, Andrea Zambruni, Gian Luca Grazi, Bruno Nardo, Matteo Ravaioli, Cristina Rossi, Rita Golfieri
Although the etiology of liver disease affects the features of hepatocellular carcinoma (HCC) diagnosed during surveillance, it is not known whether it influences patients' survival. We analyzed the impact of etiology on the characteristics and outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761abed9efed6655680140abd524e7a1
http://hdl.handle.net/11567/229088
http://hdl.handle.net/11567/229088
Autor:
BUCCI, LAURA, GARUTI, FRANCESCA, LENZI, BARBARA, PISCAGLIA, FABIO, ZOLI, MARCO, BERNARDI, MAURO, TREVISANI, FRANCO, BOLONDI, LUIGI, BISELLI, MAURIZIO, CARACENI, PAOLO, CUCCHETTI, ALESSANDRO, DOMENICALI, MARCO, GRAMENZI, ANNAGIULIA, Camelli, V, Farinati, F, Giannini, E, Ciccarese, F, Rapaccini, G, Di Marco, M, Caturelli, E, Borzio, F, Sacco, R, Maida, M, Felder, M, Morisco, F, Gasbarrini, A, Gemini, S, Foschi, F, Missale, G, Masotto, A, Affronti, A, Italian Liver Cancer Group
Publikováno v:
Alimentary pharmacologytherapeutics. 43(3)
Summary Background Hepatitis C virus (HCV) and alcohol abuse are the main risk factors for hepatocellular carcinoma (HCC) in Western countries. Aim To investigate the role of alcoholic aetiology on clinical presentation, treatment and outcome of HCC
Autor:
Vitale A, Burra P, Frigo AC, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Cillo U, Italian Liver Cancer group, TREVISANI, FRANCO, PISCAGLIA, FABIO, ZOLI, MARCO, BERNARDI, MAURO, BOLONDI, LUIGI, BISELLI, MAURIZIO, CARACENI, PAOLO, CUCCHETTI, ALESSANDRO, DOMENICALI, MARCO, GRAMENZI, ANNAGIULIA
Publikováno v:
Journal of hepatology. 62(3)
Background & Aims The role of hepatic resection for hepatocellular carcinoma (HCC) in different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at measuring the survival benefit of resection vs. non-surgical-therapies in each B
Autor:
Edoardo G. Giannini, Vincenzo Savarino, Fabio Farinati, Francesca Ciccarese, Gianludovico Rapaccini, Mariella Di Marco, Luisa Benvegnu, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, The Italian Liver Cancer group [. . ., Virginia Erroi, Donatella Magalotti, Sabina Olmi, Emanuela Giampalma, Rita Golfieri, DOMENICALI, MARCO, ZOLI, MARCO, TREVISANI, FRANCO, BERNARDI, MAURO, BISELLI, MAURIZIO, CASSINI, ROMINA, CARACENI, PAOLO, CUCCHETTI, ALESSANDRO, GRAMENZI, ANNAGIULIA, RAVAIOLI, MATTEO, BALSAMO, CLAUDIA, MOSCONI, CRISTINA, RENZULLI, MATTEO, ROSELLI, PAMELA, RISSO, DAVIDE, BOSCO, GIOVANNA
Background: The role of clinically significant portal hypertension on the prognosis of cirrhotic patients undergoing hepatic resection for hepatocellular carcinoma (HCC) is debated. Aims: In this study, our aim was to assess the role of clinically si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07467fa2ca40b3d90aa9f87c7e2f3dc9
http://hdl.handle.net/11585/254695
http://hdl.handle.net/11585/254695